TY - JOUR
T1 - Identification of developmentally regulated mesodermal-specific transcript in mouse embryonic metanephros
AU - Kanwar, Yashpal S.
AU - Kumar, Anil
AU - Ota, Kosuke
AU - Lin, Sun
AU - Wada, Jun
AU - Chugh, Sumant
AU - Wallner, Elisabeth I.
PY - 2002
Y1 - 2002
N2 - Mesodermal-specific cDNA or transcript (MEST) was identified by suppression subtractive hybridization-PCR of cDNA isolated from embryonic day 13 vs. newborn mice kidneys. At day 13 of mouse gestation, a high expression of MEST, with a single ∼2.7-kb transcript that was exclusively localized to the metanephric mesenchyme was observed. The MEST mRNA expression gradually decreased during the later stages and then abruptly decreased in the newborn kidneys and subsequent postnatal life, after which a very mild expression persisted in the glomerular mesangium. Regression in mRNA expression during embryonic renal development appears to be related to methylation of the MEST gene. Treatment of metanephroi, harvested at day 13 of gestation with MEST-specific antisense oligodeoxynucleotide resulted in a dose-dependent decrease in the size of the explants and the nephron population. This was associated with a selective decrease in MEST mRNA expression and accelerated apoptosis of the mesenchyme. These findings suggest that MEST, a gene with a putative mesenchymal cell-derived protein, conceivably plays a role in mammalian metanephric development.
AB - Mesodermal-specific cDNA or transcript (MEST) was identified by suppression subtractive hybridization-PCR of cDNA isolated from embryonic day 13 vs. newborn mice kidneys. At day 13 of mouse gestation, a high expression of MEST, with a single ∼2.7-kb transcript that was exclusively localized to the metanephric mesenchyme was observed. The MEST mRNA expression gradually decreased during the later stages and then abruptly decreased in the newborn kidneys and subsequent postnatal life, after which a very mild expression persisted in the glomerular mesangium. Regression in mRNA expression during embryonic renal development appears to be related to methylation of the MEST gene. Treatment of metanephroi, harvested at day 13 of gestation with MEST-specific antisense oligodeoxynucleotide resulted in a dose-dependent decrease in the size of the explants and the nephron population. This was associated with a selective decrease in MEST mRNA expression and accelerated apoptosis of the mesenchyme. These findings suggest that MEST, a gene with a putative mesenchymal cell-derived protein, conceivably plays a role in mammalian metanephric development.
KW - Mesenchyme gene expression
KW - Renal development
UR - http://www.scopus.com/inward/record.url?scp=0036083590&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036083590&partnerID=8YFLogxK
U2 - 10.1152/ajprenal.00200.2001
DO - 10.1152/ajprenal.00200.2001
M3 - Article
C2 - 11934706
AN - SCOPUS:0036083590
SN - 0363-6127
VL - 282
SP - F953-F965
JO - American Journal of Physiology - Renal Physiology
JF - American Journal of Physiology - Renal Physiology
IS - 5 51-5
ER -